Crispr Therapeutics Ag (CRSP)

Free Cash Flow Growth

24.02%

Quarterly · Period ending:

CRSP logo

CRSP Free Cash Flow Growth

Year-over-year change vs the same period a year earlier

Latest reported24.02%
CRSP Quarterly Free Cash Flow YoY % (-547.25% → 24.02%)
High-resolution chart · PNG

CRSP free cash flow growth history

Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.

Crispr Therapeutics Ag Free Cash Flow Growth — Quarterly
Period endingFree Cash Flow Growth
24.0164%
-102.022%
-85.085%
20.9312%
-18.3905%
-149.6675%
48.0586%
-155.2342%
29.6133%
1,799.4948%
18.9995%
62.2655%
9.7542%
103.8117%
-25.5175%
6.0341%
-119.4702%
-39.8395%
-8.885%
-45.7444%
2,467.5739%
-95.2054%
-3,707.7145%
-162.0217%
14.7111%
-23.045%
108.2528%
733.9077%
-49.8018%
-92.8925%
-95.2017%
-9.5271%
-48.7316%
12.9378%
23.4015%
-36.8299%
-18.1148%
-160.5602%
-128.677%
-135.1586%
-426.6355%
-547.2521%
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.